Likewise, stimulation of SUCNR1 on hepatic stellate cells may promote fibrosis and non-alcoholic steatohepatitis (NASH), again suggesting a benefit to blocking succinate signaling. This evidence concerns the gene SUCNR1 and metabolic dysfunction-associated steatohepatitis.